Carbocisteine Nursing Responsibilities: Monitoring & Patient Education

Carbocisteine (carbocysteine) is a mucolytic used for viscous mucus in COPD, bronchiectasis, chronic bronchitis. Nursing care focuses on safety and adherence.

Key Responsibilities

  1. Medication Reconciliation: Verify dose (adult: 750 mg TID initially, then 750 mg BID maintenance), route (PO), allergies.
  2. Interaction Screening: Caution with antibiotics (may reduce absorption), antitussives (counterproductive), other mucolytics.
  3. Adverse Effect Monitoring:
    • GI: Nausea, diarrhea, abdominal pain, GI bleed (rare).
    • Hepatic: Elevate LFTs—monitor baseline/periodic.
    • CNS: Headache, dizziness.
    • Hypersensitivity: Rash, angioedema, anaphylaxis—stop drug, treat emergently.
  4. Respiratory Assessment: Document sputum volume/viscosity/color, breath sounds, SpO2, RR pre/post therapy.
  5. Patient Education:
    • Take with food to reduce GI upset.
    • Hydrate well (2–3 L/day) to optimize mucolysis.
    • Do not combine with cough suppressants.
    • Report black/tarry stools, severe abdominal pain, rash, breathing worsening.
    • Complete prescribed course; don't stop early.
  6. Documentation: Response, side effects, teaching provided, plan modifications.

Special Populations

  • Pregnancy: Category B—use if benefit > risk.
  • Renal/hepatic impairment: Dose adjustment may be needed.
  • Pediatric: Dose by weight; syrup formulation available.

Carbocisteine is generally well-tolerated; vigilance for GI and hepatic effects ensures safe use.

Nursing Homes - Related Articles